Thymulin 10mg
Thymic Nonapeptide for Immune Regulation and Inflammation Research
Thymulin is a thymic nonapeptide (FTS) that requires zinc cofactor for biological activity, promoting T-cell differentiation, suppressing autoimmune responses, and showing analgesic and anti-inflammatory properties in research models.
Thymic Nonapeptide for Immune Regulation and Inflammation Research
Thymulin (Facteur Thymique Sérique) is produced by thymic epithelial cells and peaks in childhood, declining with age as the thymus involutes. Research shows it suppresses Th17 responses, reduces neuroinflammation, and has been studied for chronic pain and autoimmune conditions.
As one of the most studied compounds in the recovery & healing research space, Thymulin has attracted sustained scientific interest across Immune regulation research, Autoimmune disease studies, Pain and neuroinflammation research. Peer-reviewed evidence indicates that reduces neuroinflammatory pain in chronic models, which has positioned Thymulin as a reference standard for researchers exploring immune regulation research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
Thymulin Documented Benefits: 3 Documented Mechanisms
T-Cell Differentiation
Promotes thymic T-cell maturation, particularly beneficial as immune competence declines with age.
Anti-Inflammatory
Suppresses Th17 and pro-inflammatory cytokines while promoting Treg immune balance.
Analgesic Properties
Reduces chronic and neuropathic pain via hypothalamic and spinal cord mechanisms.
How Thymulin Works: Molecular Mechanism & Pathway
Zinc-dependent thymic nonapeptide activating T-cell differentiation via nuclear thymulin receptor and suppressing inflammatory Th17 polarization.
The 3 primary research pathways identified for Thymulin — T-Cell Differentiation, Anti-Inflammatory, Analgesic Properties — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that promotes T-cell maturation in aged immune models, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, Thymulin's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
Thymulin is routinely studied alongside KPV and TA-1 in recovery & healing-focused compound panels. Researchers investigating immune regulation research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that suppresses Th17-driven autoimmune pathology has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All Thymulin research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Reduces neuroinflammatory pain in chronic models
- Promotes T-cell maturation in aged immune models
- Suppresses Th17-driven autoimmune pathology
Ideal For
- Immune regulation research
- Autoimmune disease studies
- Pain and neuroinflammation research
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on Thymulin. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Reduces neuroinflammatory pain in chronic models
Promotes T-cell maturation in aged immune models
Suppresses Th17-driven autoimmune pathology
Third-Party Verified Every Batch
Each vial of Thymulin is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
